FDA Inspection 1067861 — Kabco Pharmaceuticals, Inc.

Kabco Pharmaceuticals, Inc. — FEI 2434805

The FDA completed an inspection of Kabco Pharmaceuticals, Inc. on October 2, 2018 in Amityville, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Food/Cosmetics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 2, 2018
Fiscal Year
2019
Product Type
Food/Cosmetics
Project Area
Food Composition, Standards, Labeling and Econ
Location
Amityville, NY (United States)

Citations

IDCFRDescription
10005n/aProcedural requirements